Macula Edema
11
0
0
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
18.2%
2 terminated out of 11 trials
75.0%
-11.6% vs benchmark
27%
3 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (11)
Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema
An Innovative Chinese Herbal Formula for Macular Edema
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis
Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Intraoperative Berger Space Imaging (IBSI)
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification